Anna leads the Strategy & Corporate Finance Practice for Switzerland and coleads M&A strategy and portfolio for the Life Sciences Practice around the world. She is a globally recognized merger management and carve-out advisor specializing in advising boards and management teams in designing, planning, and executing complex, cross-border integrations, separations, and alliances. She also helps her clients develop M&A blueprint and build M&A capabilities.
Anna has close to twenty years of M&A experience, advising clients in buying and selling across the entire M&A value chain. She has supported more than 110 M&A deals, ranging from $200 million to $50 billion. While her industry focus is on life sciences, she has worked across multiple industries, ranging from consumer and industrials to technology.
Anna also has extensive consulting, corporate, and private-equity experience. She regularly lectures on M&A topics at business schools across Europe and has authored numerous studies.
In addition to her work with M&A, she is also passionate about diversity and has served in multiple roles and boards to further diversity and inclusion.